112 related articles for article (PubMed ID: 37606163)
1. N6-Methyladenosine Modification and Prognostic Analysis of UBE2K in Hepatocellular Carcinoma: A Potential Target.
Guo J; Zhao J
Crit Rev Eukaryot Gene Expr; 2023; 33(8):41-55. PubMed ID: 37606163
[TBL] [Abstract][Full Text] [Related]
2. UBE2K promotes the malignant progression of hepatocellular carcinoma by regulating c-Myc.
Lei X; Hu X; Lu Q; Yao Y; Sun W; Ma Q; Huang D; Xu Q
Biochem Biophys Res Commun; 2023 Jan; 638():210-218. PubMed ID: 36481361
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-induced UBE2K promotes the malignant progression of HCC.
Ouyang G; Fu W; Guo J; Lu Q; Yao Y; Ge L; Zhao J; Zhang J; Hu X; Li S; Xu Q; Huang D; Zhang Y
Pathol Res Pract; 2023 May; 245():154422. PubMed ID: 37003132
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis
Guo J; Wang M; Wang JP; Wu CX
World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276
[TBL] [Abstract][Full Text] [Related]
5. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
6. Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma.
Deng M; Fang L; Li SH; Zhao RC; Mei J; Zou JW; Wei W; Guo RP
Mutagenesis; 2021 Oct; 36(5):369-379. PubMed ID: 34467992
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression.
Ren X; Li A; Ying E; Fang J; Li M; Yu J
Bioengineered; 2021 Dec; 12(1):1530-1542. PubMed ID: 33934686
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of ubiquitin-conjugating enzyme E2 S overexpression in hepatocellular carcinoma.
Ma Y; Li K; Li S; Liang B; Liu Q; Mo Z
Int J Biol Macromol; 2018 Nov; 119():225-231. PubMed ID: 30041036
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of the N6-methyladenosine RNA methylation regulator ZC3H13 as a novel prognostic marker and potential target for hepatocellular carcinoma.
Wu S; He G; Liu S; Cao Y; Geng C; Pan H
Int J Med Sci; 2022; 19(4):618-630. PubMed ID: 35582419
[TBL] [Abstract][Full Text] [Related]
10. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
Tian F; Cai D
Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
[TBL] [Abstract][Full Text] [Related]
11. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.
Qu S; Jin L; Huang H; Lin J; Gao W; Zeng Z
BMC Cancer; 2021 Jun; 21(1):686. PubMed ID: 34112124
[TBL] [Abstract][Full Text] [Related]
12. UBE2K regulated by IGF2BP3 promotes cell proliferation and stemness in pancreatic ductal adenocarcinoma.
Fu W; Lei X; Lu Q; Zhang J; Guo J; Zhao J; Tong X; Hu X
Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36896783
[TBL] [Abstract][Full Text] [Related]
13. Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth.
Yan Y; Chen Y; Pan J; Xing W; Li Q; Wang Y; Gei L; Yuan Y; Xie J; Zeng W; Chen D
BMC Cancer; 2022 Dec; 22(1):1248. PubMed ID: 36456906
[TBL] [Abstract][Full Text] [Related]
14. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B
J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796
[TBL] [Abstract][Full Text] [Related]
15. Circ_0000291 contributes to hepatocellular carcinoma tumorigenesis by binding to miR-1322 to up-regulate UBE2T.
Wang F; Zhong S; Mao C; Jin J; Wang H
Ann Hepatol; 2022; 27(5):100722. PubMed ID: 35569812
[TBL] [Abstract][Full Text] [Related]
16. High Level of Ubiquitin Conjugate Enzyme E2O Indicates Poor Prognosis of Patients with Hepatocellular Carcinoma.
Lan SY; Ding Y; Wang C; Fang J; Ren C; Liu JL; Kang H; Chang Y
Curr Med Sci; 2023 Feb; 43(1):93-103. PubMed ID: 36269535
[TBL] [Abstract][Full Text] [Related]
17. MiR-20b-5p promotes hepatocellular carcinoma cell proliferation, migration and invasion by down-regulating CPEB3.
Li Z; Wu L; Tan W; Zhang K; Lin Q; Zhu J; Tu C; Lv X; Jiang C
Ann Hepatol; 2021; 23():100345. PubMed ID: 33812045
[TBL] [Abstract][Full Text] [Related]
18. Characterization of prognostic value and immunological roles of RAB22A in hepatocellular carcinoma.
Wen F; Meng F; Li X; Li Q; Liu J; Zhang R; Zhao Y; Zhang Y; Wang X; Ju S; Cui Y; Lu Z
Front Immunol; 2023; 14():1086342. PubMed ID: 36936971
[TBL] [Abstract][Full Text] [Related]
19. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
20. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
[No Abstract] [Full Text] [Related]
[Next] [New Search]
